A 10,000 Character Limit Won't Solve Pharma's Twitter "Problem"

Doug Weinbrenner, senior director of social media at marketing firm Intouch Solutions, suggests that Twitter's plan to extend its 140-character limit to 10,000 will put the platform "back into [pharma marketers'] consideration set" because marketers are stymied by FDA regulations requiring important safety information (i.e., side effects) to fit in a 140-character Rx-branded tweet (see here).

He thinks this will be "revolutionary" for pharma marketers: "Twitter revolutionizing the platform is probably one of the biggest things that happened in social media over the last year, and there's a considerable amount of interest in us being at the forefront of social pharma," he said.

But there's one possible fly in the ointment that will continue to stymie pharma marketers.

Read more »